HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

CEO

Dr. Malte Peters M.D.

Employees

Country

ISIN

US43906K2096

Listings

OTC Link

HOOK

0 Comments

Share your thoughts

FAQ

What is Hookipa Pharma stock price today?▼

The current price of HOOK is $1.09 USD — it has increased by +3.81% in the past 24 hours. Watch Hookipa Pharma stock price performance more closely on the chart.

What is Hookipa Pharma stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Hookipa Pharma stocks are traded under the ticker HOOK.

Is Hookipa Pharma stock price growing?▼

HOOK stock has risen by +0.93% compared to the previous week, the month change is a +6.86% rise, over the last year Hookipa Pharma has showed a +18.9% increase.

What is Hookipa Pharma market cap?▼

Today Hookipa Pharma has the market capitalization of 10.82M

What is Hookipa Pharma revenue for the last year?▼

Hookipa Pharma revenue for the last year amounts to 87.89M USD.

What is Hookipa Pharma net income for the last year?▼

HOOK net income for the last year is -87.01M USD.

How many employees does Hookipa Pharma have?▼

As of April 02, 2026, the company has 82 employees.

In which sector is Hookipa Pharma located?▼

Hookipa Pharma operates in the Health Care sector.

When did Hookipa Pharma complete a stock split?▼

The last stock split for Hookipa Pharma was on July 10, 2024 with a ratio of 1:10.

Where is Hookipa Pharma headquartered?▼

Hookipa Pharma is headquartered in New York, US.